Harold W. Koenigsberg, M.D., DLFAPA is Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai and is director of the Mood and Personality Disorders Program at Mount Sinai. Dr. Koenigsberg is known internationally for his work in the area of mood and personality disorders. He has been funded as principal investigator on 6 National of Institute of Mental Health R01 research grants. He is an author of two books on borderline personality disorder, one of which has been published in seven languages. He has published widely on the neurobiology, phenomenology and treatment of borderline personality disorder and has also published on the psychobiology of depression, anxiety disorders and schizotypal personality disorder.
Dr. Koenigsberg’s primary area of interest is in the integration of psychological experience with underlying neural processes. A principal focus of his interest is the inter-relationship between neurobiologic, psychological and social contributors to personality and its disorders. Dr. Koenigsberg has been awarded 17 years of continuous funding as principal investigator of R01 research grants funded by the National Institute of Mental Health. Dr. Koenigsberg’s current work focuses on mood regulation, social cognitive neuroscience and in the psychobiology and treatment of borderline and schizotypal personality disorders. He is currently conducting several fMRI studies which image the brain’s activity during emotional processing and during memory retention processes in healthy volunteers and in patients with borderline personality disorder, avoidant personality disorder, schizotypal personality disorder, schizophrenia, and trans-diagnostically across the affective instability spectrum. He is also studying the role of second messenger systems in emotional instability in the personality disorders.
Dr. Koenigsberg is a Distinguished Life Fellow of the American Psychiatric Association and a Fellow of the American College of Neuropsychopharmacology. He is an emeritus member of the American College of Psychiatrists. He served as an advisor to the Personality Disorders task forces of both the DSM-IV and DSM-5 American Psychiatric Association diagnostic classification systems. He is a member of the editorial board of the Journal of Personality Disorders and has served on the Scientific Program Committee of the Society for Biological Psychiatry. Dr. Koenigsberg is a member of the board of directors of the International Society for the Study of Personality Disorders. He co-chaired the 11th International Congress of the International Society for the Study of Personality Disorders. In addition to his medical degree, Dr. Koenigsberg holds an MA in Physics from Columbia University.
Interests:
Psychotherapy
Financial & Billing Information
Please direct any detailed billing or financial inquires to the Mount Sinai Psychiatry billing customer service number at 212-659-8752.
Language
English
Position
PROFESSOR | Psychiatry
Hospital Affiliations
Mount Sinai Queens
The Mount Sinai Hospital
Research Topics
Brain Imaging, Imaging, Neuroscience
Multi-Disciplinary Training Areas
Neuroscience [NEU]
Show More
About Me
Harold W. Koenigsberg, M.D., DLFAPA is Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai and is director of the Mood and Personality Disorders Program at Mount Sinai. Dr. Koenigsberg is known internationally for his work in the area of mood and personality disorders. He has been funded as principal investigator on 6 National of Institute of Mental Health R01 research grants. He is an author of two books on borderline personality disorder, one of which has been published in seven languages. He has published widely on the neurobiology, phenomenology and treatment of borderline personality disorder and has also published on the psychobiology of depression, anxiety disorders and schizotypal personality disorder.
Dr. Koenigsberg’s primary area of interest is in the integration of psychological experience with underlying neural processes. A principal focus of his interest is the inter-relationship between neurobiologic, psychological and social contributors to personality and its disorders. Dr. Koenigsberg has been awarded 17 years of continuous funding as principal investigator of R01 research grants funded by the National Institute of Mental Health. Dr. Koenigsberg’s current work focuses on mood regulation, social cognitive neuroscience and in the psychobiology and treatment of borderline and schizotypal personality disorders. He is currently conducting several fMRI studies which image the brain’s activity during emotional processing and during memory retention processes in healthy volunteers and in patients with borderline personality disorder, avoidant personality disorder, schizotypal personality disorder, schizophrenia, and trans-diagnostically across the affective instability spectrum. He is also studying the role of second messenger systems in emotional instability in the personality disorders.
Dr. Koenigsberg is a Distinguished Life Fellow of the American Psychiatric Association and a Fellow of the American College of Neuropsychopharmacology. He is an emeritus member of the American College of Psychiatrists. He served as an advisor to the Personality Disorders task forces of both the DSM-IV and DSM-5 American Psychiatric Association diagnostic classification systems. He is a member of the editorial board of the Journal of Personality Disorders and has served on the Scientific Program Committee of the Society for Biological Psychiatry. Dr. Koenigsberg is a member of the board of directors of the International Society for the Study of Personality Disorders. He co-chaired the 11th International Congress of the International Society for the Study of Personality Disorders. In addition to his medical degree, Dr. Koenigsberg holds an MA in Physics from Columbia University.
Interests:
Psychotherapy
Financial & Billing Information
Please direct any detailed billing or financial inquires to the Mount Sinai Psychiatry billing customer service number at 212-659-8752.
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
Patients with Healthfirst Medicare Advantage insurance: Effective , Mount Sinai’s primary care providers (internal medicine, family practice, and geriatrics) are not accepting new Healthfirst Medicare patients. Please contact Healthfirst for help finding a primary care provider. Healthfirst Medicare members who have a relationship with a Mount Sinai primary care provider can continue to book appointments with them.
Physician Office1100 Park Avenue, Suite 1B, New York, NY, 10029
Medicare - NJ
Medicare - NY
NJ Medicaid
NY Medicaid
United Health Care - Top Tier
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Koenigsberg during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Board Service
Hope for Depression Research Foundation
Psychoanalytic Research & Development Fund, Inc.
International Society for the Study of Personality Disorders (ISSPD)
Editorial Services
Journal of Personality Disorders
Journal of Borderline Personality Disorder and Emotion Dysregulation
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Show More
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Koenigsberg during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Board Service
Hope for Depression Research Foundation
Psychoanalytic Research & Development Fund, Inc.
International Society for the Study of Personality Disorders (ISSPD)
Editorial Services
Journal of Personality Disorders
Journal of Borderline Personality Disorder and Emotion Dysregulation
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.